The Medulloblastoma Initiative (MBI) announces a new partnership with Einstein Hospital Israelita, a collaboration that brings together two leading institutions in science and innovation with a shared purpose: to accelerate progress in the research and treatment of pediatric brain tumors.
Recognized for its excellence in care, education, research, and social responsibility, Einstein combines tradition and innovation to transform medicine through knowledge, ethics, and social commitment.
The MBI, in turn, is an international philanthropic initiative that connects families, scientists, and world-class institutions to drive discoveries that can change the future for children with medulloblastoma. Since its creation, it has promoted unique collaborations among universities, hospitals, and research centers of global relevance.
This partnership with Einstein represents another strategic step toward strengthening a global network dedicated to impactful science, one that values scientific rigor, transparency, and a commitment to real results.
Purpose-driven science always finds worthy allies.
